0001415889-23-011122.txt : 20230714 0001415889-23-011122.hdr.sgml : 20230714 20230714162920 ACCESSION NUMBER: 0001415889-23-011122 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230712 FILED AS OF DATE: 20230714 DATE AS OF CHANGE: 20230714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Furlong Tammy CENTRAL INDEX KEY: 0001984204 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40523 FILM NUMBER: 231089416 MAIL ADDRESS: STREET 1: C/O ELEVATION ONCOLOGY, INC. STREET 2: 888 SEVENTH AVENUE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Elevation Oncology, Inc. CENTRAL INDEX KEY: 0001783032 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 841771427 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 BUSINESS PHONE: 212-651-6380 MAIL ADDRESS: STREET 1: 888 SEVENTH AVE STREET 2: 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10106 FORMER COMPANY: FORMER CONFORMED NAME: 14ner Oncology, Inc. DATE OF NAME CHANGE: 20190719 4 1 form4-07142023_080716.xml X0407 4 2023-07-12 0001783032 Elevation Oncology, Inc. ELEV 0001984204 Furlong Tammy C/O ELEVATION ONCOLOGY, INC. 888 SEVENTH AVENUE, 12TH FLOOR NEW YORK NY 10106 false true false false CHIEF FINANCIAL OFFICER 0 Stock Option (Right to Buy) 1.51 2023-07-12 4 A 0 53433 0 A 2033-07-11 Common Stock 53433 53433 D The stock option vests as to 25% of the total shares on July 12, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date. /s/ Robert Yang, Attorney-in-Fact 2023-07-14